501
Participants
Start Date
June 30, 2007
Primary Completion Date
May 31, 2010
Study Completion Date
October 31, 2010
pregabalin (Lyrica)
150 mg/day double blind (divided doses)
pregabalin (Lyrica)
300 mg/day double blind (divided doses)
matched placebo
matched placebo
Pfizer Investigational Site, Kowloon
Pfizer Investigational Site, Krugersdorp
Pfizer Investigational Site, Johannesburg
Pfizer Investigational Site, Parktown
Pfizer Investigational Site, Newcastle
Pfizer Investigational Site, Ladysmith
Pfizer Investigational Site, Cape Town
Pfizer Investigational Site, Bangkoknoi
Pfizer Investigational Site, Cadiz
Pfizer Investigational Site, Pittsburgh
Pfizer Investigational Site, Pittsburgh
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Mobile
Pfizer Investigational Site, Muang
Pfizer Investigational Site, Valencia
Pfizer Investigational Site, Muang
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Glendale
Pfizer Investigational Site, Pasadena
Pfizer Investigational Site, Glendale
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Calgary
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Sherbrooke
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Shatin
Pfizer Investigational Site, Birmingham
Pfizer Investigational Site, Pretoria
Pfizer Investigational Site, Lund
Pfizer Investigational Site, Örebro
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Leicester
Pfizer Investigational Site, Edinburgh
Pfizer Investigational Site, Liverpool
Pfizer Investigational Site, Livingstone
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY